BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 35833264)

  • 1. The advanced lung cancer inflammation index is the optimal inflammatory biomarker of overall survival in patients with lung cancer.
    Song M; Zhang Q; Song C; Liu T; Zhang X; Ruan G; Tang M; Xie H; Zhang H; Ge Y; Li X; Zhang K; Yang M; Li Q; Liu X; Lin S; Xu Y; Xu H; Wang K; Li W; Shi H
    J Cachexia Sarcopenia Muscle; 2022 Oct; 13(5):2504-2514. PubMed ID: 35833264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The derived neutrophil to lymphocyte ratio can be the predictor of prognosis for COVID-19 Omicron BA.2 infected patients.
    Qiu W; Shi Q; Chen F; Wu Q; Yu X; Xiong L
    Front Immunol; 2022; 13():1065345. PubMed ID: 36405724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Handgrip weakness, systemic inflammation indicators, and overall survival in lung cancer patients with well performance status: A large multicenter observational study.
    Song M; Zhang Q; Song C; Liu T; Zhang X; Ruan G; Tang M; Zhang X; Xie H; Zhang H; Ge Y; Li X; Zhang K; Yang M; Li Q; Liu X; Lin S; Xu Y; Li B; Li X; Wang K; Xu H; Li W; Shi H
    Cancer Med; 2023 Feb; 12(3):2818-2830. PubMed ID: 36073671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison and exploration of the prognostic value of the advanced lung cancer inflammation index, prognostic nutritional index, and systemic immune-inflammation index in newly diagnosed diffuse large B-cell lymphoma.
    Liu T; Ye F; Li Y; Liu A
    Ann Palliat Med; 2021 Sep; 10(9):9650-9659. PubMed ID: 34628890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Value of the Systemic Immune-Inflammation Index in Predicting Survival Outcomes in Patients with Brain Metastases of Non-Small-Cell Lung Cancer Treated with Stereotactic Radiotherapy.
    Zhang Y; Chen Z; Jin F; Guo D; Chen Q; Liu Z; Ji S; Gao G
    Mediators Inflamm; 2021; 2021():2910892. PubMed ID: 34744510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic effect of sixteen malnutrition/inflammation-based indicators on the overall survival of chemotherapy patients.
    Liu T; Liu C; Deng L; Song M; Lin S; Shi H
    Front Immunol; 2023; 14():1117232. PubMed ID: 36875131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic value of prognostic nutritional index (PNI) and neutrophil to lymphocyte ratio (NLR) for advanced non-small cell lung cancer treated with platinum-based chemotherapeutics.
    Wang J; Liu Y; Mi X; Shao M; Liu L
    Ann Palliat Med; 2020 May; 9(3):967-978. PubMed ID: 32389020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
    Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
    J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of the Advanced Lung Cancer Inflammation Index (ALI) in assessing the prognosis of patients with hepatocellular carcinoma treated with camrelizumab: a retrospective cohort study.
    Li Q; Ma F; Tsilimigras DI; Åberg F; Wang JF
    Ann Transl Med; 2022 Nov; 10(22):1233. PubMed ID: 36544677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of the modified systemic inflammation score in non-small-cell lung cancer with brain metastasis.
    Wang F; Chen L; Wang Z; Xu Q; Huang H; Wang H; Li X; Yu M; Chen J; Lin F; Chen Z; Zhang X; Yang Q; Mou Y; Guo C
    Cancer Cell Int; 2022 Oct; 22(1):320. PubMed ID: 36242047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of the advanced lung cancer inflammation index in early-stage non-small cell lung cancer patients undergoing video-assisted thoracoscopic pulmonary resection.
    Wang Y; Lin L; Ji Y; Mei X; Zhao C; Chen Y; Che G
    Ann Palliat Med; 2020 May; 9(3):721-729. PubMed ID: 32312059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of advanced lung cancer inflammation index (ALI) in elderly patients with heart failure.
    Yuan X; Huang B; Wang R; Tie H; Luo S
    Front Cardiovasc Med; 2022; 9():934551. PubMed ID: 36440019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depression in association with neutrophil-to-lymphocyte, platelet-to-lymphocyte, and advanced lung cancer inflammation index biomarkers predicting lung cancer survival.
    Andersen BL; Myers J; Blevins T; Park KR; Smith RM; Reisinger S; Carbone DP; Presley CJ; Shields PG; Carson WE
    PLoS One; 2023; 18(2):e0282206. PubMed ID: 36827396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common nutritional/inflammatory indicators are not effective tools in predicting the overall survival of patients with small cell lung cancer undergoing first-line chemotherapy.
    Tian H; Li G; Hou W; Jin J; Wang C; Ren P; Wang H; Wang J; Li W; Liu D
    Front Oncol; 2023; 13():1211752. PubMed ID: 37576904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Significance of Modified Advanced Lung Cancer Inflammation Index in Patients With Renal Cell Carcinoma Undergoing Laparoscopic Nephrectomy: A Multi-Institutional, Propensity Score Matching Cohort Study.
    Mao W; Wang K; Wu Y; Ni J; Zhang H; Wang Y; Wu Z; Liu R; Geng J; Chen S; Chen M
    Front Nutr; 2021; 8():781647. PubMed ID: 35127784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer.
    Tong YS; Tan J; Zhou XL; Song YQ; Song YJ
    J Transl Med; 2017 Oct; 15(1):221. PubMed ID: 29089030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of the advanced lung cancer inflammation index (ALI) for patients with neuroblastoma.
    Qi C; Zhou Y; Hu Z; Niu H; Yue F; An H; Chen Z; Wang P; Wang L; Duan G
    J Int Med Res; 2022 Jun; 50(6):3000605221109382. PubMed ID: 35770522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inflammatory burden index is a superior systemic inflammation biomarker for the prognosis of non-small cell lung cancer.
    Xie H; Ruan G; Wei L; Deng L; Zhang Q; Ge Y; Song M; Zhang X; Lin S; Liu X; Yang M; Song C; Zhang X; Shi H
    J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):869-878. PubMed ID: 36852672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The advanced lung cancer inflammation index is an independent prognostic factor after surgical resection in patients with non-small-cell lung cancer.
    Tomita M; Ayabe T; Nakamura K
    Interact Cardiovasc Thorac Surg; 2018 Feb; 26(2):288-292. PubMed ID: 29049691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Systemic Inflammation and Overall Survival in Elderly Patients with Cancer Cachexia - Results from a Multicenter Study.
    Ruan GT; Yang M; Zhang XW; Song MM; Hu CL; Ge YZ; Xie HL; Liu T; Tang M; Zhang Q; Zhang X; Zhang KP; Li XR; Li QQ; Chen YB; Yu KY; Cong MH; Wang KH; Shi HP
    J Inflamm Res; 2021; 14():5527-5540. PubMed ID: 34737602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.